LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | SB590885 | 10 | uM | LJP5 | 72 | hr | 1209 | 409 | 4203 | 0.0977 | -0.4537 |
MDA-MB-231 | Fedratinib | 10 | uM | LJP5 | 72 | hr | 1235 | 398 | 4660 | 0.0849 | -0.4514 |
MDA-MB-231 | Alvocidib | 10 | uM | LJP6 | 72 | hr | 1235 | 414 | 4405 | 0.0943 | -0.4498 |
MDA-MB-231 | A443654 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 414 | 4405 | 0.0940 | -0.4497 |
Hs 578T | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 658 | 147 | 3761 | 0.0393 | -0.4481 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP6 | 72 | hr | 1235 | 436 | 4405 | 0.0982 | -0.4446 |
MCF7 | AT-7519 | 10 | uM | LJP6 | 72 | hr | 1209 | 443 | 4012 | 0.1106 | -0.4408 |
MDA-MB-231 | CGP60474 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 407 | 4660 | 0.0875 | -0.4405 |
MDA-MB-231 | Alvocidib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 432 | 4405 | 0.0979 | -0.4377 |
MCF 10A | LDN-193189 | 10 | uM | LJP5 | 72 | hr | 962 | 136 | 10512 | 0.0130 | -0.4374 |
MCF7 | YM 201636 | 10 | uM | LJP5 | 72 | hr | 1209 | 435 | 4203 | 0.1038 | -0.4341 |
MDA-MB-231 | WH-4-025 | 10 | uM | LJP5 | 72 | hr | 1235 | 420 | 4660 | 0.0906 | -0.4310 |
Hs 578T | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 658 | 154 | 3933 | 0.0392 | -0.4301 |
MCF7 | JNK-9L | 1.11 | uM | LJP6 | 72 | hr | 1209 | 460 | 4012 | 0.1147 | -0.4285 |
MDA-MB-231 | Alvocidib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 447 | 4405 | 0.1017 | -0.4260 |
MDA-MB-231 | PF431396 | 10 | uM | LJP5 | 72 | hr | 1235 | 433 | 4660 | 0.0931 | -0.4225 |
MDA-MB-231 | Mitoxantrone | 1.11 | uM | LJP6 | 72 | hr | 1235 | 456 | 4405 | 0.1038 | -0.4198 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 459 | 4405 | 0.1041 | -0.4182 |
BT-20 | Omipalisib | 10 | uM | LJP6 | 72 | hr | 1097 | 428 | 3673 | 0.1164 | -0.4180 |
MCF7 | CGP60474 | 10 | uM | LJP6 | 72 | hr | 1209 | 474 | 4012 | 0.1186 | -0.4179 |
BT-20 | CGP60474 | 10 | uM | LJP6 | 72 | hr | 1097 | 427 | 3673 | 0.1165 | -0.4176 |
MDA-MB-231 | PF562271 | 10 | uM | LJP6 | 72 | hr | 1235 | 460 | 4405 | 0.1045 | -0.4169 |
MDA-MB-231 | WZ3105 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 446 | 4660 | 0.0961 | -0.4133 |
MDA-MB-231 | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 470 | 4405 | 0.1069 | -0.4121 |
MDA-MB-231 | CGP60474 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 448 | 4660 | 0.0962 | -0.4119 |